Menu

#Intismeran

3 posts

Feed·
3 of 3 posts
Moderna CEO on what’s next after success in cancer vaccine
📰
0Read More

Moderna CEO on what’s next after success in cancer vaccine

Business - Latest - Google News·25 days ago
#qoVQjunt
#world#news#statnews#stat#biotech

Moderna's CEO Stéphane Bancel on what's next after the recent success of a cancer vaccine, and how that impacts the company's business strategy.

15s
These Melanoma Patients Got a Vaccine Made for Their Own Tumors. 2 Years Later, 82% Are Still Cancer-Free
📰
0Read More

These Melanoma Patients Got a Vaccine Made for Their Own Tumors. 2 Years Later, 82% Are Still Cancer-Free

An apparent leak prompted Merck and Moderna to release the full trial results ahead of schedule, but investors puzzlingly greeted the good news by sending the companies’ stock prices down.

15s
Moderna, Merck’s experimental cancer vaccine cuts melanoma recurrence risk by 42%: Report
📰
0Read More

Moderna, Merck’s experimental cancer vaccine cuts melanoma recurrence risk by 42%: Report

The Indian Express·29 days ago
#cNVSqN0N
#indianexpress#study#vaccine#intismeran#risk

The vaccine, called intismeran, is tailored to each patient’s tumour. The science behind the cancer drug is based on Nobel Prize-winning mRNA technology, which was also behind Covid-19 vaccines.

15s